
ABEL Microsampler® Receives FDA Listing, Expanding Access to Nasal Liquid Biopsies for Research and Diagnostics
ABEL Microsampler® Gains FDA Class I Listing, Enhancing U.S. Research and Diagnostics with Advanced Nasal Liquid Biopsies MENLO PARK, CA, UNITED STATES, March 26, 2025 /EINPresswire.com/ -- Diag-Nose.io, a leader in precision respiratory diagnostics, is …